Complications

Injectable Fillers in Aesthetic Medicine

Volumn , Issue , 2006, Pages 67-77

  Rzany, B ^a   Zielke, H ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350017002     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/3-540-32447-X_6     Document Type: Chapter

References (42)

1. Alcalay J et al. (2003) Late-onset granulomatous reaction to Artecoll. Dermatol Surg 29(8):859-862
2. Andre P (2004) Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA - Q-Medical, Sweden) in European countries: a retrospective study from 1997 to 2001. J Eur Acad Dermatol Venereol 18(4):422-425
3. Apte RS et al. (2003) Acute choroidal infarction following subcutaneous injection of micronized dermal matrix in the forehead region. Retina 23(4):552-554
4. Bergeret-Galley C et al. (2001) The value of a new filler material in corrective and cosmetic surgery: DermaLive and DermaDeep. Aesthetic Plast Surg 25(4):249-255
5. Breiting V et al. (2004) A Study on Patients Treated with Polyacrylamide Hydrogel Injection for Facial Corrections. Aesthetic Plast Surg 28(1):45-53
6. Cheonis N (2002) New-Fill to treat facial wasting. Beta 15(2):10-15
7. Charriere G et al. (1987) Reactions to a bovine collagen implant. Clinical and immunologic study in 705 patients. J Am Acad Dermatol 21(6):1203-1208
8. Cooperman LS et al. (1985) Injectable collagen: a six-year clinical investigation. Aesthetic Plast Surg 9(2):145-151
9. De Cassia Novaes W, Berg A (2003) Experiences with a New Nonbiodegradable Hydrogel (Aquamid): A Pilot Study. Aesthetic Plast Surg 27(5):376-380
10. De Lustro F et al. (1987) Reaction to injectable collagen: results in animal models and clinical use. Plast Reconstr Surg 79(4):581-594
11. Ersek RA et al. (1997) Bioplastique at 6 years: clinical outcome studies. Plast Reconstr Surg 100(6):1570-1574
12. Fagien S (2000) Facial soft-tissue augmentation with injectable autologous and allogeneic human tissue collagen matrix (autologen and dermalogen). Plast Reconstr Surg 105(1):362-373; discussion 374-375
13. Fernandez-Acenero MJ et al. (2003) Granulomatous foreign body reaction against hyaluronic acid: report of a case after lip augmentation. Dermatol Surg 29(12):1225-1226
14. Ficarra G et al. (2002) Silicone granuloma of the facial tissues: a report of seven cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94(1):65-73
15. Fitzpatrick RE (1999) Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 25(3):224-232
16. Friedman PM et al. (2002) Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 28(6):491-494
17. Hoffmann C et al. (1999) Adverse reactions after cosmetic lip augmentation with permanent biologically inert implant materials. J Am Acad Dermatol 40(1):100-102
18. Homicz MR, Watson D (2004) Review of injectable materials for soft tissue augmentation. Facial Plast Surg 20(1):21-29
19. Lemperle G et al. (1998) PMMA-Microspheres (Artecoll) for long-lasting correction of wrinkles: refinements and statistical results. Aesthetic Plast Surg 22(5):356-365
20. Lemperle G et al. (2003) Soft tissue augmentation with artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg 29(6):573-587; discussion 587
21. Lombardi T et al. (2004) Orofacial granulomas after injection of cosmetic fillers. Histopathologic and clinical study of 11 cases. J Oral Pathol Med 33(2):115-120
22. Lowe NJ (2003) Arterial embolization caused by injection of hyaluronic acid (Restylane). Br J Dermatol 148(2):379; author reply 379-380
23. Lowe NJ et al. (2001) Hyaluronic acid skin fillers: adverse reactions and skin testing. J Am Acad Dermatol 45(6):930-933
24. Lupton JR, Alster TS (2000) Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Dermatol Surg 26(2):135-137
25. Micheels P (2001) Human anti-hyaluronic acid antibodies: is it possible? Dermatol Surg 27(2):185-91
26. Moody BR, Sengelmann RD (2000) Self-limited adverse reaction to human-derived collagen injectable product. Dermatol Surg 26(10):936-938
27. Moyle GJ et al. (2004) A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med 5(2):82-87
28. Protopapa C et al. (2003) Bio-Alcamid in drug-induced lipodystrophy. J Cosmet Laser Ther 5(3-4):226-230
29. Rapaport MJ et al. (1996) Injectable silicone: cause of facial nodules, cellulitis, ulceration, and migration. Aesthetic Plast Surg 20(3):267-276
30. Raulin C et al. (2000) Exudative granulomatous reaction to hyaluronic acid (Hylaform). Contact Dermatitis 43(3):178-179
31. Reisberger EM et al. (2003) Foreign body granulomas caused by polymethylmethacrylate microspheres: successful treatment with allopurinol. Arch Dermatol 139(1):17-20
32. Requena C et al. (2001) Adverse reactions to injectable aesthetic microimplants. Am J Dermatopathol 23(3):197-202
33. Rudolph CM et al. (1999) Foreign body granulomas due to injectable aesthetic microimplants. Am J Surg Pathol 23(1):113-117
34. ®) in der Ästhetischen Medizin: Ergebnisse des ersten deutschen Konsensustreffens an der Charité. Ästhetische Dermatologie: 3
35. Shafir R et al. (2000) Long-term complications of facial injections with Restylane (injectable hyaluronic acid). Plast Reconstr Surg 106(5):1215-1216
36. Sklar JA, White SM (2004) Radiance FN: a new soft tissue filler. Dermatol Surg 30(5):764-768; discussion 768
37. Strom BL (1994) What is Pharmacoepidemiology? In: Strom BL (ed) Pharmacoepidemiology, 2nd edn. Wiley, New York
38. Tzikas TL (2004) Evaluation of the Radiance FN soft tissue filler for facial soft tissue augmentation. Arch Facial Plast Surg 6(4):234-239
39. ®) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. Aids 17(17):2471-2477
40. Wang YB et al. (2003) [Clinically analyzing the possible side-effects after injecting hydrophilic polyacrylamide gel as a soft-tissue filler]. Zhonghua Zheng Xing Wai Ke Za Zhi 19(5):328-330
41. Waris E (2003) Alloplastic injectable biomaterials for soft tissue augmentation: a report on two cases with complications associated with a new material (DermaLive) and a review of the literature. Eur J Plast Surg 26:350-355
42. Wölber L et al. (2005) Risiken Injizierbarer Füllmaterialien, Ergebnisse der Injectable Filler Safety - Study. J Dtsch Dermatol Ges 3(Suppl.1):140